Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evolut™ EXPAND TAVR II Pivotal Trial

NCT: NCT05149755 · ACTIVE_NOT_RECRUITING

NCT IDNCT05149755
StatusACTIVE_NOT_RECRUITING
Start Date2022-04-27
SponsorMedtronic Cardiovascular (INDUSTRY)
First posted
Last updated

Brief Summary

Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑